Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial

OBJECTIVES: To address whether sparing the medial retropharyngeal lymph node (MRLN) region from elective irradiation volume provides non-inferior local relapse-free survival versus standard radiotherapy in patients with nasopharyngeal carcinoma. DESIGN: Open-label, non-inferiority, multicentre, rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Yan-Ping, Wang, Shun-Xin, Gao, Tian-Sheng, Zhang, Ning, Liang, Xiao-Yu, Xie, Fang-Yun, Zhang, Yuan, Zhou, Guan-Qun, Guo, Rui, Luo, Wei-Jie, Li, Yong-Jie, Liang, Shao-Qiang, Lin, Li, Li, Wen-Fei, Liu, Xu, Xu, Cheng, Chen, Yu-Pei, Lv, Jia-Wei, Huang, Shao-Hui, Liu, Li-Zhi, Li, Ji-Bin, Tang, Ling-Long, Chen, Lei, Sun, Ying, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900470/
https://www.ncbi.nlm.nih.gov/pubmed/36746459
http://dx.doi.org/10.1136/bmj-2022-072133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900470/
https://www.ncbi.nlm.nih.gov/pubmed/36746459
http://dx.doi.org/10.1136/bmj-2022-072133

Ejemplares similares